Gsk Says EU Authorisation Of GSK s RSV Vaccine Arexvy marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
By Christian Moess Laursen GSK said Wednesday that it has received authorization for its respiratory syncytial virus vaccine Arexvy from the European Commission, the executive body of the. | June 7, 2023
GSK PLC on Wednesday announced that its RSV vaccine Arexvy has become the first EU-backed vaccine against the respiratory syncytial virus for adults aged 60 and older.
The European Commission. | June 7, 2023
European regulators have approved the
region s first vaccine for respiratory syncytial virus ,
which causes thousands of hospitalisations and deaths annually. The shot, called Arexvy, is. | June 7, 2023
European regulators have approved the
region s first vaccine for respiratory syncytial virus ,
which causes thousands of hospitalisations and deaths annually. The shot, called Arexvy, is. | June 7, 2023